Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
The proposed models intend to test a payment model that modifies the inflation rebate using international drug pricing information
CMS recently announced that payments to Medicare Advantage plans will increase by 5.06%, drawing support from payer advocates. The post Payer Advocates Applaud 5% MA Payment Increase appeared first on MedCity News.
For other IV fluids still in short supply, the FDA is working with manufacturers to monitor the supply, FDA Commissioner states
At Frederick Health in Maryland, a determination to move forward into the future
Peter McCaffrey, M.D., M.S., chief digital and AI officer at UT Medical Branch, and Bunkerhill Health’s Azita Hamedani, M.D., M.P.H., M.B.A., discuss deployment of an agentic platform
AAMC says U. of Chicago Medicine and Pritzker School of Medicine embed community engagement into every aspect of medical education, research, and clinical care
Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild…
By integrating industry standards into e-prescribing software, prescribing organizations can reduce errors to improve patient outcomes and lessen the burden of medication-related errors on healthcare systems. Here’s a look at the new National Council for Prescription Drug Programs (NCPDP) Sig Standard aimed at improving prescription accuracy. The post The Key to Solving Medication Errors is…
Medicaid work requirements may make it more difficult for some SSI applicants to maintain coverage due to the added complexity of navigating the verification process for the medical frailty exclusion. KFF’s policy analysis explains why SSI applicants are particularly at risk of going uninsured under the new Medicaid rules.